Objectives: To evaluate the characteristics, methods, and results of the Du
tch Investigative Medicine Program ("ontwikkelingsgeneeskunde") in policy a
nd health care.
Methods: Project database analyses of the initial 9 years of the program; d
escription of characteristics, methods, and effects of the program.
Results: By the end of 1997, 53 projects had been completed, including impl
ementation in health care policy. In 20 at 53 cases the program worked as a
n instrument to prevent the introduction of ineffective, inefficient, or ev
en harmful medical interventions. In most other cases the program assisted
with proper placement or appropriate application of new technologies,Apart
from new or emerging technologies, already existing technologies are evalua
ted.
Conclusion: The Dutch Investigative Medicine Program ("ontwikkelingsgeneesk
unde") of the Sickness Funds Council is an effective collaboration of healt
h care providers, medical science, health economics, and a regulatory body
in empirical technology assessment. It is also-an example not only of a sub
stantial contribution of technology assessment to decision making in practi
ce and policy but also of a means of regulation of health care by the very
activity of technology assessment itself. It appears that the program has e
volved into an instrument to rationalize health care and health care policy
, although some further possible improvements are identified.